The Drug-Induced Respiratory Disease Website
Patients with drug-induced lupus may present with serositis (See Vd). Review at PMID 20015613. Compendium of 118 drugs causing lupus from the Who Phamacovigilance Database available at PMID 30793701. A few drugs (Penicillamine, IFN, anti-TNF agents) can cause +ds-DNA lupus. Drug withdrawal is followed by abatement of signs, symptoms and diminution or disappearance of anti-nuclear antibodies (ANA). See also under Vd.
Publications
Anti-tumour necrosis factor-?-induced lupus in a patient receiving infliximab for sarcoidosis.
Respirology case reports 2022 Aug;10;e01006 — 2022 Aug — e01006
Arnaud L, Mertz P, Gavand PE, Martin T, Chasset F, Tebacher-Alt M, Lambert A, Muller C, Sibilia J, Lebrun-Vignes B, Salem JE
Drug-induced systemic lupus: revisiting the ever-changing spectrum of the disease using the WHO pharmacovigilance database.
Annals of the rheumatic diseases 2019 04;78;504-508 — 2019 04 — 504-508
Infliximab-Induced Lupus: A Case Report.
GE Portuguese journal of gastroenterology 2017 Mar;24;84-88 — 2017 Mar — 84-88
Jani M, Dixon WG, Kersley-Fleet L, Bruce IN, Chinoy H, Barton A, Lunt M, Watson K, , , Symmons DP, Hyrich KL
Drug-specific risk and characteristics of lupus and vasculitis-like events in patients with rheumatoid arthritis treated with TNFi: results from BSRBR-RA.
RMD open 2017;3;e000314 — 2017 — e000314
Recurrent drug-induced ANCA vasculitis in a patient with Crohn's colitis treated with infliximab: a potential contraindication to immunosuppressive therapy.
The American surgeon 2012 Dec;78;1406-8 — 2012 Dec — 1406-8
Safety of infliximab in Crohn's disease: a large single-center experience.
Inflammatory bowel diseases 2010 Dec;16;2109-16 — 2010 Dec — 2109-16
Arterial thrombosis with anti-phospholipid antibodies induced by infliximab.
European journal of dermatology : EJD 2007 Nov-Dec;17;546-7 — 2007 Nov-Dec — 546-7
Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials.
Arthritis and rheumatism 2000 Nov;43;2383-90 — 2000 Nov — 2383-90